Premium
ATAI Life Sciences NV (ATAI)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA d... ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany. Show more
- The United States Food and Drug Administration cleared the investigational new drug application for VLS-01 (buccal film DMT); atai expects to initiate a Phase 2 study in treatment-resistant...
GAITHERSBURG, Md., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Greg Weaver as Chief Financial...
NEW YORK and BERLIN, Oct. 15, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.11 | -8.20895522388 | 1.34 | 1.36 | 1.15 | 1502577 | 1.21598766 | CS |
| 4 | -0.47 | -27.6470588235 | 1.7 | 1.809 | 1.15 | 1228264 | 1.44504877 | CS |
| 12 | 0.07 | 6.03448275862 | 1.16 | 1.95 | 1.03 | 1431746 | 1.4300802 | CS |
| 26 | -0.13 | -9.55882352941 | 1.36 | 1.95 | 1.03 | 996954 | 1.40293082 | CS |
| 52 | -0.17 | -12.1428571429 | 1.4 | 2.85 | 1.03 | 1231084 | 1.71437438 | CS |
| 156 | -6.15 | -83.3333333333 | 7.38 | 8.15 | 1.025 | 1043682 | 2.44523185 | CS |
| 260 | -0.6 | -32.7868852459 | 1.83 | 22.91 | 1.025 | 818143 | 3.47826001 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
